These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32951459)

  • 21. Treatment of persistent epithelial defects with single-dose autologous serum eye drops.
    Özbek-Uzman S; Yalnız-Akkaya Z; Şingar Özdemir E; Burcu A
    Eur J Ophthalmol; 2022 Jul; 32(4):2159-2165. PubMed ID: 34585599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of topical insulin in ocular surface restoration: A review.
    Krolo I; Behaegel J; Termote K; de Bruyn B; De Schepper M; Oellerich S; Ní Dhubhghaill S
    Surv Ophthalmol; 2024; 69(5):805-817. PubMed ID: 38609022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undiluted Serum Eye Drops for the Treatment of Persistent Corneal Epitheilal Defects.
    Lekhanont K; Jongkhajornpong P; Anothaisintawee T; Chuckpaiwong V
    Sci Rep; 2016 Dec; 6():38143. PubMed ID: 27909310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical study of therapeutic ocular surface medium for persistent epithelial defect.
    Watson SL; Geerling G; Dart JK
    Ophthalmic Res; 2014; 51(2):82-7. PubMed ID: 24335180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent epithelial defects due to neurotrophic keratopathy treated with a substance p-derived peptide and insulin-like growth factor 1.
    Nishida T; Chikama T; Morishige N; Yanai R; Yamada N; Saito J
    Jpn J Ophthalmol; 2007; 51(6):442-7. PubMed ID: 18158595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens.
    Rosenthal P; Cotter JM; Baum J
    Am J Ophthalmol; 2000 Jul; 130(1):33-41. PubMed ID: 11004257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation.
    Prabhasawat P; Tesavibul N; Komolsuradej W
    Br J Ophthalmol; 2001 Dec; 85(12):1455-63. PubMed ID: 11734521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Autologous Serum Eye Drops with Contact Lenses in the Treatment of Chemical Burn-Induced Bilateral Corneal Persistent Epithelial Defects.
    Chen YM; Wang WY; Lin YC; Tsai SH; Lou YT
    Biomed Res Int; 2022; 2022():6600788. PubMed ID: 35237689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized Clinical Trial of Topical Insulin Versus Artificial Tears for Healing Rates of Iatrogenic Corneal Epithelial Defects Induced During Vitreoretinal Surgery in Diabetics.
    Dasrilsyah AM; Wan Abdul Halim WH; Mustapha M; Tang SF; Kaur B; Ong EY; Bastion MLC
    Cornea; 2023 Nov; 42(11):1395-1403. PubMed ID: 37267451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined application of autologous serum eye drops and silicone hydrogel lenses for the treatment of persistent epithelial defects.
    Choi JA; Chung SH
    Eye Contact Lens; 2011 Nov; 37(6):370-3. PubMed ID: 21983552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical Treatment of Persistent Epithelial Defects with a Matrix Regenerating Agent.
    Sevik MO; Turhan SA; Toker E
    J Ocul Pharmacol Ther; 2018 Nov; 34(9):621-627. PubMed ID: 30312119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular surface deficits contributing to persistent epithelial defect after penetrating keratoplasty.
    Fu Y; Liu J; Tseng SC
    Cornea; 2012 Jul; 31(7):723-9. PubMed ID: 22495035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autologous serum for otherwise therapy resistant corneal epithelial defects - Prospective report on the first 70 eyes].
    Ferreira de Souza R; Kruse FE; Seitz B
    Klin Monbl Augenheilkd; 2001 Nov; 218(11):720-6. PubMed ID: 11731899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy.
    Nagano T; Nakamura M; Nakata K; Yamaguchi T; Takase K; Okahara A; Ikuse T; Nishida T
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3810-5. PubMed ID: 12939296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Wilson MW; Hungerford JL; George SM; Madreperla SA
    Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery.
    Lekhanont K; Jongkhajornpong P; Choubtum L; Chuckpaiwong V
    Biomed Res Int; 2013; 2013():521315. PubMed ID: 23984378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Autologous Serum Gel in Neurotrophic Persistent Corneal Epithelial Defects Combined with Lagophthalmos.
    Kim HJ; Youn HC; Hyun JJ; Kim SW
    Ophthalmol Ther; 2022 Dec; 11(6):2129-2139. PubMed ID: 36152214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical insulin, a novel corneal epithelial regeneration agent in dry eye disease.
    Burgos-Blasco B; Diaz-Valle D; Rego-Lorca D; Perez-Garcia P; Puebla-Garcia V; Fernandez-Vigo JI; Benitez-Del-Castillo JM; Gegundez-Fernandez JA
    Eur J Ophthalmol; 2024 May; 34(3):719-725. PubMed ID: 37814519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects.
    Erdem E; Yagmur M; Harbiyeli I; Taylan-Sekeroglu H; Ersoz R
    Int J Ophthalmol; 2014; 7(5):807-10. PubMed ID: 25349797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical anesthetic abuse keratopathy: a commonly overlooked health care problem.
    Yagci A; Bozkurt B; Egrilmez S; Palamar M; Ozturk BT; Pekel H
    Cornea; 2011 May; 30(5):571-5. PubMed ID: 21598429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.